Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07820943) titled 'Dermatological Acceptability and Efficacy in Improving Xerosis, Skin Hydration, and Barrier Function' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Brainfarma Industria Quimica e Farmaceutica S/A
Condition:
Xerosis
Dry Skin
Intervention:
Other: moisturizing cream
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: September 14, 2026
Target Sample Size: 22
Countries of Recruitment:
Brazil
To know more, visit https://clinicaltrials.gov/study/NCT0...